Antipsychotic drug action: antagonism, inverse agonism or partial agonism
Data up to Jan 2025
Total Citations Per Year
Abstract
References (57)
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 • 5,799 citations
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
1989 • 1,313 citations
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
1996 • 1,275 citations
Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia
2006 • 1,117 citations
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 • 1,076 citations
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 • 1,036 citations
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 • 996 citations
Increased dopamine transmission in schizophrenia: relationship to illness phases
1999 • 713 citations
Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence
2001 • 686 citations
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
1997 • 358 citations
Dopamine D2 and D3 Receptor Occupancy in Normal Humans Treated with the Antipsychotic Drug Aripiprazole (OPC 14597) A Study Using Positron Emission Tomography and [11C]Raclopride
2002 • 299 citations
Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.
2000 • 290 citations
Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia
2003 • 276 citations
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
1995 • 268 citations
Aripiprazole
2004 • 262 citations
Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.
2001 • 235 citations
Differential Effects of Aripiprazole on D2, 5-HT2, and 5-HT1AReceptor Occupancy in Patients With Schizophrenia: A Triple Tracer PET Study
2007 • 234 citations
Aripiprazole for schizophrenia
2006 • 233 citations
Human pharmacological MRI
2004 • 213 citations
Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP
1983 • 200 citations
Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways
2006 • 188 citations
Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4Dopamine Receptors: Identification of the Clozapine MetaboliteN-Desmethylclozapine as a D2/D3Partial Agonist
2005 • 182 citations
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies
2004 • 173 citations
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate
1995 • 148 citations
Inverse agonism and the regulation of receptor number
1997 • 142 citations
Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
1987 • 133 citations
(+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists
1986 • 132 citations
Aripiprazole for schizophrenia
2006 • 124 citations
Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors
1997 • 116 citations
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 • 107 citations
Agonist binding, agonist affinity and agonist efficacy at G protein‐coupled receptors
2008 • 106 citations
Aripiprazole, a novel antipsychotic drug, inhibits quinpriole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum
1997 • 101 citations
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
2006 • 90 citations
Functional coupling of the human dopamine D2 receptor with Gαi1, Gαi2, Gαi3 and Gαo G proteins: evidence for agonist regulation of G protein selectivity
2003 • 88 citations
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia
1997 • 82 citations
The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system
1988 • 75 citations
Aripiprazole acts as a selective dopamine D2receptor partial agonist
2007 • 71 citations
Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3
2007 • 65 citations
Neuropharmacological profile of bifeprunox: merits and limitations in comparison with other third-generation antipsychotics.
2007 • 60 citations
Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.
1998 • 59 citations
Constitutive Activity of a Chimeric D2/D1Dopamine Receptor
1997 • 59 citations
Mechanisms of inverse agonism of antipsychotic drugs at the D2 dopamine receptor: use of a mutant D2 dopamine receptor that adopts the activated conformation
2001 • 58 citations
Occupancy of dopamine D 2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications
2003 • 55 citations
Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia
2005 • 53 citations
Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells
1999 • 52 citations
Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
1998 • 49 citations
Antipsychotics with inverse agonist activity at the dopamine D3 receptor
1996 • 47 citations
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties
2006 • 47 citations
Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary
1998 • 42 citations
Effects of the D 3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia
1998 • 38 citations
Haloperidol increases prolactin release and cyclic AMP formation in vitro: inverse agonism at dopamine D2 receptors?
1993 • 36 citations
Mechanisms of inverse agonist action at D2 dopamine receptors
2005 • 35 citations
Assays for enhanced activity of low efficacy partial agonists at the D2 dopamine receptor
2006 • 25 citations
Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist
2006 • 24 citations
Characterization of dopaminergic compounds at hD 2short , hD 4.2 and hD 4.7 receptors in agonist-stimulated [ 35 S]GTPγS binding assays
2000 • 20 citations
Pharmacological analysis of a dopamine D2Short:Gαo fusion protein expressed in Sf9 cells
2003 • 18 citations
Constitutive Coupling of a Chimeric Dopamine D2/α1BReceptor to the Phospholipase C Pathway: Inverse Agonism to Silent Antagonism by Neuroleptic Drugs
2003 • 11 citations